Standout Papers
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 (2016)
- European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines (2020)
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer (2016)
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update (2015)
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 (2013)
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update (2019)
- European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) (2021)
- EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines (2013)
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update (2020)
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update (2017)
- EAU Guidelines on Penile Cancer: 2014 Update (2014)
- The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours (2022)
- Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up (2021)
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update (2023)
- Current best practice for bladder cancer: a narrative review of diagnostics and treatments (2022)
- The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma (2021)
- Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors (2023)
- The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors (2022)
- Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up (2024)
- ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma (2024)
- European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update (2024)
Immediate Impact
11 from Science/Nature 63 standout
Citing Papers
A vision–language foundation model for precision oncology
2025 StandoutNature
Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice
2024 Standout
Works of Éva Compérat being referenced
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Éva Compérat | 14269 | 5750 | 4736 | 353 | 19.7k | |
| George N. Thalmann | 7958 | 5473 | 3513 | 316 | 15.3k | |
| Willet F. Whitmore | 10940 | 6748 | 2765 | 359 | 17.9k | |
| J. Alfred Witjes | 16949 | 9367 | 5785 | 404 | 27.0k | |
| Colin P. Dinney | 12572 | 4512 | 3111 | 490 | 21.3k | |
| Antonio López-Beltrán | 7396 | 6868 | 1921 | 531 | 15.9k | |
| Yves Fradet | 8517 | 5083 | 2096 | 375 | 15.7k | |
| Stephen A. Boorjian | 8998 | 11786 | 2404 | 560 | 20.1k | |
| Bernard H. Bochner | 14006 | 3081 | 5886 | 330 | 17.1k | |
| Ashish M. Kamat | 12756 | 3082 | 3659 | 526 | 18.1k | |
| Seth P. Lerner | 12218 | 2926 | 3714 | 368 | 15.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...